Marketing-authorisation holder
Arafarma Group S.A.
78 medicines in 1 country, as authorisation holder, manufacturer and marketer.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 78
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ARACENAC 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG100 mg · Comprimido recubierto con película | Aceclofenac | Spain | Marketed | 2008 |
| ARAFRIOL POLVO PARA SOLUCION ORAL500 mg + 4 mg + 10 mg · Granulado | Paracetamol, Chlorpheniramine, Phenylephrine | Spain | Authorised | 1992 |
| ARAGEL 50 mg/g GEL50 mg · GEL | Ibuprofen | Spain | Authorised | 2010 |
| ARALEVO 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG5 mg · Comprimido recubierto con película | Levocetirizina dihidrocloruro | Spain | Marketed | 2010 |
| ARAPRIDE 10 mg CAPSULAS10 mg · Cápsula dura gastrorresistente | Omeprazole | Spain | Marketed | 2003 |
| ARAPRIDE 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG20 mg · Cápsula dura gastrorresistente | Omeprazole | Spain | Marketed | 2003 |
| ARAPRIDE 40 mg CAPSULAS DURAS GASTRORRESISTENTES40 mg · Cápsula dura gastrorresistente | Omeprazole | Spain | Marketed | 2003 |
| ARATRO 200 mg/5 ml POLVO PARA SUSPENSION ORAL EN FRASCO EFG200 mg · Polvo para suspensión oral | Azithromycin | Spain | Marketed | 2003 |
| ARATRO 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG500 mg · Comprimido recubierto con película | Azithromycin | Spain | Marketed | 2003 |
| ARATRO 500 mg POLVO PARA SUSPENSION ORAL EN SOBRE EFG500 mg · Polvo para suspensión oral | Azithromycin | Spain | Marketed | 2003 |
| CANDIFIX 150 mg CAPSULAS DURAS EFG150 mg · Cápsula dura | Fluconazole | Spain | Marketed | 2008 |
| DOLBAN 0,075 % CREMA(312-625) mg · Crema | Capsicum oleoresin | Spain | Marketed | 2007 |
| LEFLUARTIL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG10 mg · Comprimido recubierto con película | Leflunomide | Spain | Marketed | 2011 |
| LEFLUARTIL 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG20 mg · Comprimido recubierto con película | Leflunomide | Spain | Marketed | 2011 |
| MONOFLOX 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG512,4 mg · Comprimido recubierto con película | Levofloxacin | Spain | Marketed | 2019 |
| NITROFIX 10 mg PARCHES TRANSDERMICOS EFG53 mg · Parche transdérmico | Nitroglycerin | Spain | Marketed | 2009 |
| NITROFIX 15 mg PARCHES TRANSDERMICOS EFG80 mg · Parche transdérmico | Nitroglycerin | Spain | Marketed | 2009 |
| NITROFIX 5 mg PARCHES TRANSDERMICOS EFG26,6 mg · Parche transdérmico | Nitroglycerin | Spain | Marketed | 2009 |
| NORMOTRIDE 25 mg COMPRIMIDOS EFG25 mg · Comprimido | Carvedilol | Spain | Marketed | 2006 |
| NORMOTRIDE 6,25 mg COMPRIMIDOS EFG6,25 mg · Comprimido | Carvedilol | Spain | Marketed | 2007 |
| UROSEPTIC 3 G GRANULADO PARA SOLUCION ORAL EN SOBRES EFG5,631 g · Granulado para solución oral | Fosfomycin | Spain | Marketed | 2012 |
| ACECLOFENACO ARAFARMA GROUP 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG100 mg · Comprimido recubierto con película | Aceclofenac | Spain | Withdrawn | 2008 |
| ACYDONA SOLUCION PARA USO CUTANEO10 mg · Solución cutánea | Povidona iodada | Spain | Withdrawn | 2002 |
| ACYFLOX 500 MG / 200 MG COMPRIMIDOS EFERVESCENTES500 mg + 200 mg · Comprimido efervescente | Acetylsalicylic acid, Ascorbic acid | Spain | Withdrawn | 1964 |
| ACYLINE 620 mg/380 mg/630 mg SUSPENSION ORAL620,0 mg + 380,0 mg + 630,0 mg · Suspensión oral | Algeldrato, Hydroxide, Aluminio hidroxido-magnesio carbonato,coprecipitado | Spain | Suspended | 2005 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 78 | 21 | 57 | CompaniesAll medicines |
Also in the registers of Brazil
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- arafarma group
- arafarma group s a
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 78
- Countries
- 1
- Roles
- Authorisation holder, manufacturer and marketer



